ALNY: Prakiraan wutah bathi saben saham kanggo taun ngarep alnylam.com

Logo perusahaan publik Alnylam Pharmaceuticals (ALNY)

Supply chain disruption risks for bioccomponents and geopolitics limit patient access to Alnylam Pharmaceuticals (ALNY) therapies. However, its leadership status in RNA interference provides the company with pricing power and a stable cash flow. The GURU.Markets system provides a chart in the form of a profit growth rate model for the coming year, where the -51.80 metric determines this level, confirming the loyalty of a unique staff of geneticists.

Alnylam Pharmaceuticals, Inc. (ALNY): Prakiraan owah-owahan bathi resik saben saham kanggo taun ngarep saka 04.07.2022 nganti 17.11.2026

Rincian analitis lan laporan data perusahaan Alnylam Pharmaceuticals, Inc. (ALNY)

- rega saham lan konsensus proyeksi valuasi:
Pambiji fundamental perusahaan:ALNY, alnylam.com
Produk dadi Alnylam

The technological moat of Alnylam Pharmaceuticals (ALNY) based on its monopoly in the RNA interference sector ensures high investment reliability. This metric measures the expected earnings per share (EPS) dynamics by aggregating analyst consensus forecasts for the upcoming fiscal year. Analyzing the projected net EPS growth for year n+1 allows for the identification of shifts in institutional sentiment prior to the release of financial reports. The positive trend confirms the resilience of the business model amidst stringent FDA barriers.

Analisis perusahaan pesaing

VRTX (Vertex) - Prakiraan wutah bathi kanggo taun ngarep|Proyeksi kacepetan wutah bathi saben saham kanggo taun ngarep INSM (Insmed)|Prakiraan wutah bathi saben saham kanggo taun ngarep UTHR (United Therapeutics Corporation)|BMRN (BioMarin Pharmaceutical Inc.) - Dinamika bathi saben saham sing diarepake ing taun ngarep|Prakiraan wutah bathi resik saben saham kanggo taun ngarep BridgeBio BBIO|Dinamika bathi saben saham sing diarepake ing taun ngarep BGM|Cogent Biosciences - Prakiraan wutah bathi kanggo taun ngarep|Dinamika bathi saben saham sing diarepake ing taun ngarep XERS (Xeris Biopharma)|KROS: Prakiraan wutah bathi kanggo taun ngarep|Arcturus Therapeutics Inc (ARCT) - Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Eton Pharma|KMDA: Dinamika bathi saben saham sing diarepake ing taun ngarep|Prakiraan wutah bathi resik saben saham kanggo taun ngarep fulcrumtx.com (FULC)|Prakiraan wutah bathi saben saham kanggo taun ngarep Abeona Therapeutics Inc. ABEO|Prakiraan wutah bathi kanggo taun ngarep MREO (Mereo BioPharma Group)|PLX (Protalix BioTherapeutics Inc.) - Prakiraan owah-owahan bathi resik saben saham kanggo taun ngarep|PLRX - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|APLT - Prakiraan wutah bathi kanggo taun ngarep|RNTX: Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi resik saben saham ing taun ngarep Gelteq Limited Inc (GELS)|Prakiraan wutah bathi saben saham kanggo taun ngarep AYTU|Prakiraan wutah bathi resik saben saham ing taun ngarep chemomab.com CMMB|Prakiraan wutah bathi saben saham kanggo taun ngarep SRXH (SRx Health Solutions Inc)|PLRZ - Prakiraan wutah bathi resik saben saham ing taun ngarep|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Aeterna Zentaris AEZS|Cyclo Therapeutics, Inc. (CYTH) - Prakiraan wutah bathi resik saben saham ing taun ngarep|INZY - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|Dinamika bathi saben saham sing diarepake ing taun ngarep RPHM (Reneo Pharmaceuticals Inc.)|COSCIENS Biopharma Inc. (CSCI) - Prakiraan wutah bathi resik saben saham kanggo taun ngarep